Product Information
RIFAMPIN 150 MG CAPSULE is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.6179 per EA under NDC 68180065806. Its NADAC has been published 649 times since Jan 22, 2014.
Strength
150 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180065806
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RIFAMPINApproval Type
Generic (ANDA)
FDA Application
ANDA090034On Market Since
1/8/2014
Pharmacological Classes
Price Statistics
The NADAC for RIFAMPIN 150 MG CAPSULE has been published 649 times since Jan 22, 2014, and over the history we have for it it has declined 31.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6179 per EA |
|---|---|
| All-time high | $1.3166 (Jan 10, 2024) |
| All-time low | $0.5653 (Nov 20, 2024) |
| 52-week high | $0.8064 |
| 52-week low | $0.5959 |
| Median price | $0.8246 |
| Average price | $0.8502 |
| Largest weekly change | +94.1% (Aug 19, 2020) |
| Weeks tracked | 649 |
| Tracking since | Jan 22, 2014 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RIFAMPIN 150 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RIFAMPIN 150 MG CAPSULE, manufactured by Lupin Pharmaceuticals Inc., is $0.6179 per EA (NDC 68180065806), effective Jun 24, 2026.
How has the price of RIFAMPIN 150 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RIFAMPIN 150 MG CAPSULE has declined 31.7%. It has been tracked across 649 weekly CMS publications since Jan 22, 2014.
What are the highest and lowest recorded NADAC prices for RIFAMPIN 150 MG CAPSULE?
Since Jan 22, 2014, the NADAC for RIFAMPIN 150 MG CAPSULE has ranged from a low of $0.5653 (Nov 20, 2024) to a high of $1.3166 (Jan 10, 2024), with a median of $0.8246 per EA.
Are there cheaper alternatives to RIFAMPIN 150 MG CAPSULE?
2 NADAC-published products share the same active ingredient, strength, and dosage form as RIFAMPIN 150 MG CAPSULE, but none are currently priced below it.
Who manufactures RIFAMPIN 150 MG CAPSULE?
RIFAMPIN 150 MG CAPSULE (NDC 68180065806) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification